Anhui Anke Biotechnology (Group) Co., Ltd.
Status: Publicly traded
Direct answer
Anhui Anke Biotechnology (Group) Co., Ltd. is publicly traded on SHZ under the ticker 300009.SZ.
Anhui Anke Biotechnology (Group) Co., Ltd. is engaged in the research, manufacturing, and global distribution of pharmaceutical goods, serving both domestic Chinese and international markets. Its flagship offerings include Ansomone, a brand of recombinant human growth hormone administered via injection, and the Anterferon line, which comprises recombinant human interferon alpha 2b in various forms such as...
Can you invest in Anhui Anke Biotechnology (Group) Co., Ltd.?
Yes. Anhui Anke Biotechnology (Group) Co., Ltd. is publicly traded on SHZ under the ticker 300009.SZ.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Anhui Anke Biotechnology (Group) Co., Ltd.
Detailed equity research is provided by MarketSnap.